BNP Paribas Asset Management
HAE icon

BNP Paribas Asset Management’s Haemonetics HAE Stock Holding History

BNP Paribas Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.9M Sell
65,321
-54
-0.1% -$3.47K ﹤0.01% 901
2026
Q1 		$3.68M Buy
65,375
+245
+0.4% +$16K ﹤0.01% 938
2025
Q4 		$5.22M Buy
+65,130
New +$4.38M 0.01% 830
2025
Q3 		– Sell
-530
Closed -$40K – 1955
2025
Q2 		$40K Buy
+530
New +$35.1K ﹤0.01% 1220
2017
Q3 		– Sell
-59,700
Closed -$2.36M – 941
2017
Q2 		$2.36M Sell
59,700
-11,900
-17% -$489K 0.02% 626
2017
Q1 		$2.9M Hold
71,600
– – 0.03% 584
2016
Q4 		$2.88M Sell
71,600
-5,000
-7% -$189K 0.03% 581
2016
Q3 		$2.77M Hold
76,600
– – 0.02% 641
2016
Q2 		$2.22M Buy
76,600
+13,500
+21% +$408K 0.02% 668
2016
Q1 		$2.21M Hold
63,100
– – 0.02% 658
2015
Q4 		$2.03M Buy
63,100
+6,400
+11% +$208K 0.02% 662
2015
Q3 		$1.83M Buy
56,700
+16,800
+42% +$632K 0.02% 702
2015
Q2 		$1.65M Sell
39,900
-39,900
-50% -$1.68M 0.01% 761
2015
Q1 		$3.58M Buy
79,800
+19,100
+31% +$798K 0.03% 570
2014
Q4 		$2.27M Hold
60,700
– – 0.02% 592
2014
Q3 		$2.12M Buy
+60,700
New +$2.17M 0.02% 606

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BNP Paribas Asset Management's HAE Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Haemonetics (HAE) stake by 0.08% in Q2 2026, selling an estimated $3.47K and leaving 65,321 shares worth $4.9M. The position accounts for ﹤0.01% of the portfolio, ranked #901.

BNP Paribas Asset Management first reported a position in HAE in Q3 2014 and has held it in 16 quarters since. The position peaked at $5.22M in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • BNP Paribas Asset Management held 65,321 shares of Haemonetics worth $4.9M as of Q2 2026.
  • BNP Paribas Asset Management sold 54 Haemonetics shares in Q2 2026, an estimated $3.47K.
  • Haemonetics made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #901 holding.
  • BNP Paribas Asset Management first reported a position in Haemonetics in Q3 2014 and has held it in 16 quarters since.
  • BNP Paribas Asset Management's Haemonetics position peaked at $5.22M in Q4 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.